Dr. Robert K. Shin, MD

Dr. Shin practices at UVA University Medical Center in Charlottesville, Virginia.

Dr. Shin's NPI, 1932124385, was assigned on July 13, 2006. Dr. Shin holds Virginia license 0101273016.

Dr. Shin's primary practice is UVA University Medical Center, at 1215 Lee St, Charlottesville, VA 22908 in Charlottesville City. The practice phone is (434) 760-3439.

Dr. Shin's primary practice is UVA University Medical Center in Charlottesville, Virginia. Dr. Shin is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Shin to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shin practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Shin's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Shin's licenses on file in 2 states: Virginia and District of Columbia.

CMS data shows 54 Medicare services from Dr. Shin across 2 procedure codes in 2024, for 52 Medicare patients. Medicare paid $3,507 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 52 Medicare patients who saw Dr. Shin in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shin's median patient age at 51, with 67% women.

In 2024, Dr. Shin wrote 199 Medicare Part D claims for 67 patients. 65% of them were for generic drugs. CMS names the drug for 109 of them, across 6 drugs with 11 or more claims each, at $515,122 in total drug cost. In 2023, CMS named 330 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Shin for performance year 2024, reported as part of a group. Dr. Shin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shin as offering telehealth.

Dmand AI links 20 papers to Dr. Shin, published from 2012 to 2025. 2014 was the busiest year, with 2. The most frequent topics are Magnetic Resonance Imaging, Optic Chiasm and Optic Nerve. Dr. Shin has published most often in J Neuroophthalmol. Dr. Shin's most frequent co-authors are Uttam Kumar Bodanapally, MD, Lee Richard Katzman, MD and Luis J. Mejico, MD.

CMS Open Payments shows 2,290 general payments to Dr. Shin from 21 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Sanofi and Genzyme US Companies paid the most, $717,310. It also lists 5 research payments totaling $27,215 from 2020 to 2025.